ObjectiveTo study the clinical efficacy of Erigeron breviscapus combined with the ″central integration″ technique on lower limb dyskinesia in patients with acute ischemic stroke. MethodA total of 120 patients with acute ischemic stroke were randomly divided into 3 groups, with 40 patients in each group. During the research, 3 cases fell off in the treatment group 1, 1 case fell off in the treatment group 2, and 3 cases fell off in the control group. The control group was treated with routine symptomatic treatment and conventional rehabilitation training, based on which the treatment group 1 was treated with Erigeron breviscapus injection, and the treatment group 2 was treated with Erigeron breviscapus injection combined with ″central integration″. The Berg Balance Scale (BBS) score, Functional Ambulation Category (FAC) score, and Timed ″Up and Go″ test (TUGT) time on the 1st, 14th, and 28th days of treatment were compared between the three groups. ResultsThere was no statistically significant difference in the BBS score between the three groups (P＞0.05), but there was a statistically significant difference in the BBS score of the three groups at different time points (P＜0.05), and there existed a time*group interaction effect (P＜0.05). There were statistically significant differences in the FAC score between the three groups and in the FAC score of the three groups at different time points (all P＜0.05), and there existed a time*group interaction effect (P＜0.05). There was no statistically significant difference in TUGT time between the three groups (P＞0.05), but there was a statistically significant difference in TUGT time of the three groups at different time points (P＜0.05), and there existed a time*group interaction effect (P＜0.05). ConclusionThe intervention of Erigeron breviscapus combined with the ″central integration″ technique can improve the lower limb dyskinesia, as well as the balance and functional walking abilities in patients with acute ischemic stroke.

无